National Centre for Pharmacoeconomics https://validator.w3.org/feed/docs/rss2.html Seladelpar (Lyvdelzi®). HTA ID: 26003 Pembrolizumab (Keytruda®). HTA ID: 24013 House Dust Mite Extract (Acarizax ®) for Allergic Rhinitis (5-65 year olds) HTA ID: 25069 Amivantamab (Rybrevant®). HTA ID: 24032 Daridorexant (Quviviq®) HTA ID: 25029 Maralixibat (Livmarli®). HTA ID: 25001 Capivasertib (Truqap®). HTA ID: 24015 Glofitamab (Columvi®) in combination with gemcitabine and oxaliplatin. HTA ID: 25037 Donanemab (Kisunla®). HTA ID: 25067 Sodium Zirconium Cyclosilicate (Lokelma®). HTA ID: 24039 Durvalumab (Imfinzi®). HTA ID: 25046 Relugolix with estradiol and norethisterone acetate (Ryeqo®). HTA ID: 24018 Sotatercept (Winrevair ®). HTA ID: 24041 2025 Monthly Updates Trastuzumab deruxtecan (Enhertu®). HTA ID: 25049 Tirzepatide (Mounjaro®). HTA ID: 24024 Pegcetacoplan (Aspaveli®). HTA ID: 21064 Ravulizumab (Ultomiris®). HTA ID: 20036 Ravulizumab (Ultomiris®). HTA ID: 19054 Tremelimumab (Imjudo®) in combination with durvalumab (Imfinzi®). HTA ID: 23073 Axicabtagene ciloleucel (Yescarta®). HTA ID: 22066 Faricimab (Vabysmo ®) for visual impairment due to diabetic macular oedema. HTA ID: 22061 Faricimab (Vabysmo ®) for neovascular (wet) age-related macular degeneration. HTA ID: 22060 Liraglutide (Saxenda®) in adolescent patients. HTA ID: 24001 Crovalimab (Piasky®). HTA ID: 24027 Nivolumab (Opdivo®) for advanced or metastatic gastric, gastro oesophageal junction or oesophageal adenocarcinoma (1L). HTA ID: 21049 Pembrolizumab (Keytruda®). HTA ID: 23078 Pre-submission meetings Delgocitinib (Anzupgo®). HTA ID 26006 Amivantamab (Rybrevant®). HTA ID: 24044 Dupilumab (Dupixent®). HTA ID: 24035 Trastuzumab deruxtecan (Enhertu®). HTA ID: 24028 Pegylated Liposomal irinotecan (Onivyde). HTA ID: 24030 Givinostat (Duvyzat®). HTA ID: 25048 Monthly Updates 2026 Monthly Updates Home Niraparib + abiraterone acetate (Akeega®). HTA ID 26008 Tislelizumab (Tevimbra®). HTA ID: 25014 Durvalumab (Imfinzi®). HTA ID: 25010 Pembrolizumab (Keytruda®). HTA ID: 24049 Semaglutide (Wegovy®). HTA ID: 25024 Ruxolitinib (Opzelura®). HTA ID: 25004 Mirvetuximab soravtansine (Elahere®). HTA ID: 24051 Fezolinetant (Veoza™). HTA ID: 24005 Odevixibat (Kayfanda®). HTA ID: 26005 Amivantamab (Rybrevant®) in combination with lazertinib (Lazcluze®). HTA ID: 25006 About Us Elafibranor (Iqirvo®). HTA ID: 25005 Belzutifan (Welireg®). HTA ID: 25020